Kenny Walter

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

In a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.

Using a variety of tests to measure cognitive changes, investigators find that gender and education level does not impact cognitive decline as much as health and lifestyle factors.

In a 53-patient observational study, investigators discover they can safely transplant a HCV-infected kidney into a HCV-negative recipients.

Investigators find that opening all blockages with stents is more beneficial after a heart attack than targeting just the clogged artery causing the event.

An updated list of guidelines recommends using catheter ablation to treat supraventricular tachycardia.

In a new clinical trial, investigators found a FAAH inhibitor improves the recall of fear extinction memories while reducing the impact of stress in PTSD patients.

The FDA warns of liver failure in rare cases from taking Mavyret, Zepatier, and Vosevi to treat hepatitis C.

Investigators find a gluten-free diet does not cause abdominal pain, reflux, indigestion, diarrhea, and constipation in non-gluten sensitive patients.

A new set of 22 recommendations include a combination of universal screenings, medication, and other preventative initiatives in an effort to drive down veteran suicide rates.

In a multi-country study, investigators find that the US could reduce the number of deaths for patients waiting for kidney transplants if they accept older kidneys.

A new FDA approval allows istradefylline to be taken as an add-on with other medication to reduce the time medication does not work in Parkinson disease patients.

Despite a common belief that medications treating mental illnesses are connected to weight gain, new data shows an individual in a weight management program will lose weight whether or not they are taking antidepressants or antipsychotics.

As part of the Parkinson’s Progression Markers Initiative, researchers announce the addition of RNA sequencing dataset.

New data suggests that type 2 diabetes linked to PTSD are less likely to occur among patients with clinically meaningful PTSD symptom reduction through treatment or spontaneous improvement.

In a comprehensive new study, investigators discover unique patterns in the brains of both family members and patients with psychotic disorders, including bipolar disorder and schizophrenia.

In a new study, investigators examine the efficacy and tolerability of antipsychotic medications for patients in remission for psychotic depression.

In a new population-based study, investigators discover sex differences in burdensome interventions and antibiotic therapy for nursing home residents with advanced dementia in Canada.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

Vanda CEO expressed disappointment after FDA fails to approve jet lag disorder treatment due to unclear clinical significance.

The new device will treat patients who are not suited for other commonly used treatment options for advanced heart failure.

In a population-based cohort study, investigators discover how allergy immunotherapy helps allergic rhinitis from progressing to asthma.

The association of depression symptoms with cognition and cortical amyloid measurements could lead to better therapies to prevent Alzheimer disease.

The Tether-Vertebral Body Tethering System will help treat the most common form of idiopathic scoliosis.

After a 12-week study, investigators find a whole food diet, coupled with partial enteral nutrition, helps children with mild to moderate Crohn’s disease.

A team of investigators review global HCV infection rates in an attempt to quantify HCV-associated cardiovascular disease.

The approval marks the first ever treatment for patients with narcolepsy that is not scheduled as a controlled substance by the DEA.

A new study looks at the links between ADHD and bipolar disorder in children and adolescents.

A team of 6 hospital officials hope a comprehensive review of the 4 major hospital rating systems will yield a more uniform and reliable review process.

The August 14 approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs.